EP Patent

EP2776086B8 — Apparatus for removing chemotherapy compounds from blood

Assigned to Delcath Systems Inc · Expires 2019-03-06 · 7y expired

What this patent protects

Patent listed against melphalan-hydrochloride.

Drugs covered by this patent

melphalan-hydrochloride (MELPHALAN HYDROCHLORIDE)

Patent Metadata

Patent number: EP2776086B8
Jurisdiction: EP
Classification: —
Expires: 2019-03-06
Drug substance claim: No
Drug product claim: No
Assignee: Delcath Systems Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.